Compare MPLT & TXO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MPLT | TXO |
|---|---|---|
| Founded | 2018 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 811.3M | 690.8M |
| IPO Year | N/A | 2022 |
| Metric | MPLT | TXO |
|---|---|---|
| Price | $18.47 | $12.73 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 2 |
| Target Price | ★ $31.00 | $20.50 |
| AVG Volume (30 Days) | 162.2K | ★ 194.4K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | ★ 19.08% |
| EPS Growth | N/A | ★ 118.90 |
| EPS | N/A | ★ 0.14 |
| Revenue | N/A | ★ $282,810,000.00 |
| Revenue This Year | N/A | $39.13 |
| Revenue Next Year | N/A | $17.86 |
| P/E Ratio | ★ N/A | $90.21 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $12.24 | $10.12 |
| 52 Week High | $21.55 | $20.24 |
| Indicator | MPLT | TXO |
|---|---|---|
| Relative Strength Index (RSI) | 56.35 | 66.32 |
| Support Level | $15.78 | $12.61 |
| Resistance Level | $20.09 | $12.83 |
| Average True Range (ATR) | 1.29 | 0.35 |
| MACD | 0.10 | 0.02 |
| Stochastic Oscillator | 60.53 | 82.40 |
MapLight Therapeutics Inc is a biopharmaceutical company. The company is focused on improving the lives of patients suffering from debilitating central nervous system, or CNS, disorders. The company is engaged in psychiatry and neuroscience research to address the lack of circuit-specific pharmacotherapies available for patients. The product candidates of the company include ML-007C-MA, ML-004, ML-021, ML-009, and other pipeline products.
TXO Partners LP is focused on the acquisition, development, optimization, and exploitation of oil, natural gas, and natural gas liquid reserves in North America.